Samsung Display to invest $11Bn to develop advanced display screens
By Akshay Kedari  Date: 2019-10-11

Samsung Display to invest $11Bn to develop advanced display screens

In a bid to increase market penetration, tech company need to upgrade their product’s offering using technological innovation. Given to the importance of investment in this field, numerous tech organizations in the world have started to pour heavy investments in research and development.

A similar initiative was taken by Samsung Display, a supplier to Apple Inc., who reportedly announced that it will invest 13.1 trillion won ($11 billion) on research and on facilities to upgrade its production line to develop advanced display screens.

Reportedly, the move comes at a time when South Korea’s panel makers seem to struggle to match with decreasing liquid crystal display (LCD) demand for electronic devices along with rising competition from Chinese tech companies and increasing demand for organic light-emitting diode (OLED) panels.

According to reports, the 13.1 trillion won investment that would be spend over the next five years would be focused on converting one of Samsung Display’s South Korea-based LCD lines into a facility to mass-manufacture advanced “quantum dot” screens.

Samsung claims that it had halted its LCD production line last month. For the record, Samsung runs six display manufacturing lines, of which one LCD line sites in China. Moreover, the company is planning to overcome the crisis of the large-scale display industry through this investment.

Reportedly, Samsung Elec vice chairman Jay Y. Lee and South Korean President Moon Jae-in were present at the signing ceremony for the proposed investment at Samsung Display’s manufacturing site in the South Korean city of Asan.

Sources cite that Samsung is planning to begin operation of its advanced “quantum dot” line from 2021 with a monthly capacity of 30,000 sheets. In addition to this, in early September, the company has launched a voluntary redundancy program at large display business departments in South Korea for its employees.

Source Credit  - https://in.reuters.com/article/uk-samsung-display-investment/samsung-display-to-invest-11-billion-by-2025-amid-industry-oversupply-idINKBN1WP0C4

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...